Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
about
Docking Screens for Novel Ligands Conferring New Biology.Non-stoichiometric inhibition in integrated lead finding - a literature review.Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoVX-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design.Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold.Molecular dynamics simulations and novel drug discovery.
P2860
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Identification of novel drug s ...... and high-throughput screenings
@ast
Identification of novel drug s ...... and high-throughput screenings
@en
type
label
Identification of novel drug s ...... and high-throughput screenings
@ast
Identification of novel drug s ...... and high-throughput screenings
@en
prefLabel
Identification of novel drug s ...... and high-throughput screenings
@ast
Identification of novel drug s ...... and high-throughput screenings
@en
P2093
P2860
P921
P1476
Identification of novel drug s ...... and high-throughput screenings
@en
P2093
Anuradha Mittal
Debbie C Mulhearn
Jaime Torres
Kavankumar Patel
Lena Truong
Michael E Johnson
P2860
P304
P356
10.1016/J.BMC.2013.11.041
P407
P577
2013-12-01T00:00:00Z